# Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis: a randomized, double-blind, placebo-controlled, phase II study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-ustekinumab-in-japanese-patients-with-severe-atopic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hidehisa Saeki,Kenji Kabashima,Y. Tokura,Yoko Murata,Ai Shiraishi,Ryo Tamamura,B. Randazzo,Keiichiro Imanaka |
| Citations | 118 |
| DOI | 10.1111/bjd.15493 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjd.15493 |
| OpenAlex ID | https://openalex.org/W2601555940 |
| PMID | 28338223 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Ai Shiraishi](https://scholariq.org/researchers/ai-shiraishi/)

## Paper journal

- [British Journal of Dermatology](https://scholariq.org/journals/british-journal-of-dermatology/)

## Paper primary topic

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Paper topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Mast cells and histamine](https://scholariq.org/topics/mast-cells-and-histamine/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.